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Abstract
Background: 13-Methyltetradecanoic acid (13-MTD), an iso-C15 branched- chain saturated fatty
acid, has been shown to induce apoptotic cell death of numerous human cancer cells. However,
the mechanism for the induction of apoptosis has not been fully understood. This study described
the incorporation of 13-MTD into cellular lipid of SKBR-3 breast cancer cells and apoptosis related
event to gain more insight into the mechanism action of this fatty acid.
Results: Treatment of SKBR-3 cells with 13-MTD lowered the cell viability and induced apoptosis.
Proportion of 13-MTD in the glycerolipids increased to saturation level within 6 hours.
Triacylglycerol contained 13-MTD in higher concentration than phospholipid with positional
preference to sn-2. 13-MTD caused no changes in the caspase activity and its gene expression.
Furthermore, addition of caspase-inhibitor to culture medium did not prevent the cells from the
cytotoxicity of 13-MTD. No-increase in the cellular calcium level was also noted with 13-MTD
treatment. However, 13-MTD disrupted the mitochondrial integrity in 4 hours, and increased the
nuclear translocation of apoptosis inducing factor.
Conclusion:  These results showed that 13-MTD disrupted the mitochondrial integrity, and
induced apoptosis via caspase-independent death pathway.
Background
The branched-chain fatty acid (BCFA) or alcohols has
been reported to suppress the proliferation or develop-
ment of tumor cells [3]. Recently, 13-methyltetradecanoic
acid (13-MTD), an iso-C15 saturated fatty acid, was puri-
fied as an anti-cancer agent from a soy-fermentation prod-
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uct [4]. 13-MTD inhibited cell proliferation and induced
apoptotic cell death in many cancer cells such as prostate
carcinoma (DU-145), leukemia (K563) and mammary
adenocarcinoma (MCF-7) [4].
Induction of apoptosis was characterized by many mor-
phological features including membrane blebbing, cyto-
plasmic and nuclear condensation, DNA fragmentation
and formation of apoptotic bodies [5,6]. Our previous
study showed that 13-MTD synthetically lowered the fatty
acids biosynthesis and reduced the precursor of free fatty
acid for phospholipid synthesis in human breast cancer
cell (SKBR-3) [3]. However, the mechanism for the induc-
tion of apoptosis by 13-MTD has not been fully under-
stood.
Epidemiological studies have indicated that fatty acid
composition of the diet correlated with the risk of mam-
mary cancer [7-9]. The level of stearic acid in tumor mem-
brane phosphatidylcholine has been considered to be an
independent tumor marker of breast cancer prognosis
[10]. Furthermore, the involvement of lipogenic enzyme
in oncogenesis has suggested that the membrane lipids
could be a factor for the modulation of tumor growth
[11,12]. It is therefore possible that the incorporation of
13-MTD into membrane or storage lipid may play a role
for the induction of apoptosis in the cancer cells. Thus the
aim of this study was to describe the incorporation of 13-
MTD into cellular glycerolipid and its positional distribu-
tion in the lipid molecules. Furthermore, this study shed
the light on the effect of 13-MTD on apoptosis related
events to gain more insight into the mechanism actions of
this fatty acid.
Results
The effect of 13-MTD on the relative viability of SKBR-3
cells are shown in figure 1. Consistent with the previous
results, 13-MTD lowered the cell viability compared with
the straight chain fatty acid counterpart, but to a lesser
extent than cis-9, trans-11 conjugated linoleic acid (CLA),
a well known anticancer fatty acid. Quantitation of apop-
totic cells found that 13-MTD as well as CLA increased the
number of apoptotic cells even after treatment of 4 hours
(Fig. 2).
Figure 3 illustrates the incorporation of 13-MTD, CLA and
myristic acid into cellular glycerolipid, TG (A) and PL (B).
Proportions of 13-MTD and CLA in both PL and TG
increased with the incubation time. 13-MTD was incorpo-
rated preferentially into TG rather than PL. The propor-
tion of 13-MTD in both PL and TG increased to the
saturation level in 6 h. As was the case of 13-MTD, prefer-
ence for TG was noted with the incorporation of CLA into
cellular lipid. However, the proportion of CLA in PL was
Effect of 13-MTD on the induction of apoptotic cell death in  SKBR-3 cells Figure 2
Effect of 13-MTD on the induction of apoptotic cell death in 
SKBR-3 cells. Cells were pre-cultured for 24 h and treated 
with the fatty acid samples for another 4 h, and apoptotic 
cells were measured by Anexin V staining. Number of Anexin 
V stained cells in approximately 100 cells was counted and 
expressed as percentages of apoptotic cells. Data are mean ± 
SE of 4 analyses. Data not sharing the same letter shows sta-
tistically significant difference at p < 0.05 by Tukey-Kramer 
test.
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Effect of 13-MTD on the relative viability of SKBR-3 cells Figure 1
Effect of 13-MTD on the relative viability of SKBR-3 cells. 
Cells were treated with the fatty acid samples for 24 h, and 
the relative viabilities were determined by MTS assay kit 
according to the manufacture's instruction. Data are mean ± 
SE of 8 analyses. Data not sharing the same letter within each 
concentration are significantly different at p < 0.05 by Tukey-
Kramer test.
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much higher than that of 13-MTD, showing that CLA
accumulated in membrane lipid to a greater extent than
13-MTD.
Fatty acids taken up by the cells undergo esterification to
form membrane PL or storage TG, depending probably on
their chemical structure. The metabolic fate of fatty acid
thus showed diversity with their chemical structure, and
resulted in uneven positional distribution in TG or PL
molecules [17]. TG contained almost equal proportions
of 13-MTD at sn-2 position and at sn-1,3 positions (Fig
4A). However, this was not the case for CLA: sum of sn-1
and sn-3 position was higher than the proportion at sn-2
position.
Preferential esterification of 13-MTD to sn-2 position was
noted for PC, while this trend was more clearly shown for
the case of CLA (Fig. 4B). Incorporation of 13-MTD into
PC was higher than that into PE. CLA distributed evenly
between PC and PE.
Caspases are involved in signal transduction leading to
apoptotic cell death [18,19]. Caspase 3 acts at the final
step of caspase cascade to cleave proteins involved in
cytoskeletal and nuclear structure, resulting in the cell
shrinking and DNA fragmentation of late-stage apoptosis.
13-MTD has been demonstrated to be an anticancer agent
to induce apoptosis in a variety of cancer cells. However,
13-MTD had no effect on the activity of caspase 3 in SKBR-
3 cells. (Fig. 5A) In contrast to 13-MTD, CLA significantly
elevated the caspase 3 activity after 2 and 4 h of incuba-
tion. Despite lack of caspase 3 activation, 13-MTD
reduced the cell viability to the same extent as CLA did
(Fig. 5B).
To confirm the non-involvement of caspase pathway,
cytotoxicity and apoptosis induction were studied in the
presence of caspase 3 inhibitor (Z-DEVD-FMK) and nega-
tive control for caspase-3 inhibitor (Z-FA-FMK). The neg-
ative control (Z-FA-FMK) only inhibits cysteine protease,
and has no inhibitory effect on apoptosis mediated by cas-
pase. Presence of caspase-3 inhibitor did not alleviate the
cytotoxicity of 13-MTD (Fig. 6A), and also did not prevent
the cells from induction of apoptosis (Fig. 6B). However,
presence of the caspase inhibitor, but not the negative
control, almost abolished the cytotoxicity of CLA (Fig.
6A).
Effect of 13-MTD on the expression of several regulatory
genes involved in the apoptosis induction was studied
(data not shown). Addition of fatty acid samples evenly
decreased the expression of p53 gene with no difference
between 13-MTD and myristic acid treatment. CLA
increased mRNA level of caspase 3 as well as its activity.
Time course of 13-MTD incorporation into triacylglycerol (A) and phospholipids (B) of SKBR-3 cells Figure 3
Time course of 13-MTD incorporation into triacylglycerol (A) and phospholipids (B) of SKBR-3 cells. SKBR-3 cells grown to 
80% confluency were incubated with the fatty acid samples for 3 to 24 h, and their proportions in the total fatty acids were 
measured by gas-chromatograph. Data are mean ± SE of triplicate analyses. Data not sharing the same letter shows statistically 
significant difference at p < 0.05 by Tukey-Kramer test.
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13-MTD had no effect on the expression of caspase 8,
apoptosis inducing factor (AIF), Bax, Bad and Bcl-XL (Fig.
7).
It has been demonstrated that hydrogen peroxide medi-
ates the induction of apoptosis in response to several
external stimuli [20,21], and the supplementation of the
medium with catalase prevent the cells from apoptosis
induction [22,23]. Addition of catalase to the culture
medium did not protect or rescue the cells from cytotoxic-
ity of 13-MTD (Fig. 8). In agreement with the previous
result, presence of catalase in the culture medium pro-
tected the cells from the cytotoxicity of CLA (Fig. 8).
Several lines of studies have demonstrated that short
chain or medium chain fatty acid increased the cellular
Ca2+ mobilization via G-protein coupled orphan receptors
[24,25]. Furthermore, excess loading of mitochondria
with Ca2+ results in abnormal mitochondrial metabolism,
which triggers the programmed cell death [26]. No mobi-
lization of Ca2+ occurred when the cells were loaded with
13-MTD (Fig. 9). Oleic acid included as positive control
stimulated the cellular Ca2+ mobilization as well as the
case for CLA (Fig. 9).
As to induction of apoptosis, mitochondria play a pivotal
role in the signal transduction pathways [27]. To examine
mitochondrial membrane integrity, MitoCapture reagent
was used to stain the apoptotic cells after treatment of the
cells with 13-MTD. In healthy cells, MitoCapture accumu-
lates and aggregates in the mitochondria, and gives off a
bright red fluorescence, while in apoptotic cells, MitoCap-
ture can not enter mitochondria due to altered mitochon-
drial transmembrane potential, and therefore remain
predominantly in the cytosol in its monomer form fluo-
rescing green. After 4 hours of treatments with 13-MTD,
the MitoCapture dye fluoresced predominantly green was
indicating the disruption of mitochondrial integrity (Fig.
10). Myristic acid slightly increased the staining of green
fluorescence compared with control vehicle buffer, but to
much lower extent than 13-MTD did. CLA treatment for 4
hours liberated the cells from the bottom of the culture
dishes into medium, and resulted in staining green fluo-
rescence (Fig. 10).
The most notorious apoptotic factors released from per-
meabilized mitochondria are cytochrome C and AIF.
However, the results shown in the foregoing studies may
rule out the involvement of cytochrome C in the death
Positional distribution of 13-MTD in triacylglycerol (A) and phospholipids (B) of SKBR-3 cells Figure 4
Positional distribution of 13-MTD in triacylglycerol (A) and phospholipids (B) of SKBR-3 cells. Cells were grown to 80% conflu-
ency, and incubated with the fatty acid samples for 6 hours. Phospholipid and triacylglycerol fractions were hydrolyzed respec-
tively with lipase and phospholipase A2, and positional distribution of sample fatty acid was determined as described in the 
method section. Data are mean ± SE of triplicate analyses. Data not sharing the same letter shows statistically significant differ-
ence at p < 0.05 by Tukey-Kramer test. Asterisk shows the statistical significance between position 1,3 and position 2 by Stu-
dent's t-test.
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pathway of 13-MTD induced apoptosis. AIF was therefore
the most plausible candidate of death signal transducer
for 13-MTD induced apoptosis. Figure 11 shows the
immunodetection of AIF punctuated apoptotic nucleus
after treatment of the cells with 13-MTD. Treatment of the
cells with vehicle buffer (control) showed few nuclear
staining of AIF (Fig. 11). However, the percentage of AIF
punctuated apoptotic nuclei was significantly increased
by 13-MTD treatment (Fig. 11). This percentage was
increased to some extent by the treatment of myristic acid.
However the difference between control and myristic acid
was statistically insignificant.
Discussion
This study described the incorporation of 13-MTD into
cellular lipid, and the apoptosis related events after treat-
ment of the cells with this fatty acid. 13-MTD induced
apoptosis after 4 hours of treatment (Fig. 2), and reduced
the cell viability (Fig. 1). The cytotoxicity of 13-MTD may
be challenged by a claim that its toxic effect is due to non-
specific detergent properties of fatty acids [28]. However,
myristic acid, the straight chain fatty acid counterpart, had
no significant cytotoxicity against SKBR-3 cells. Further-
more, the detergent property of 13-MTD may have limited
significance in the current experiment because the sample
fatty acids were dissolved in a detergent buffer containing
0.8% Tween 80. The vehicle buffer (PBS containing
0.8%Ttween 80) displayed negligible effect on the cell via-
bility (data not shown). These observations negate the
possibility that the cytotoxicity of 13-MTD is due to non-
specific detergent properties of 13-MTD.
Structural membrane glycerolipids of animal cells contain
almost exclusively 14 to 22 carbon fatty acids of straight
chain with up to three methylene-interrupted double
bonds. These fatty acids were referred to as usual fatty
acids. Contrary to these fatty acids, 13-MTD is a fatty acid
with branched carbon chain, and can be classified as unu-
sual fatty acid.
Fatty acid entered the cancer cells undergo esterification to
form TG or PL, and the production of TG and PL shares a
common pathway referred to as the glycerol-3-phosphate
pathway. In plant cells, unusual fatty acids are sequestered
into storage lipid TG, and have no structural functions
[29]. In current study, the concentration of 13-MTD in TG
was higher than that found in PL. This observation may
favor the above view that the fatty acids of which chemical
structure deviate from the common fatty acids are edited
out from membrane PL, and channeled into TG (Fig. 3).
The targeting of 13-MTD to TG may be primarily
explained by the substrate specificity of the enzyme
involved in the biosynthesis of PL and TG: thioesterase,
acyltransferase and cytidine diphosphocholine diacylglyc-
erol choline phosphotransferase (CDP-CPT). Of the
enzymes, CDP-CPT catalyzes the reversible conversion of
Effect of 13-MTD on caspase-3 activity (A) and relative viability (B) of SKBR-3 cells Figure 5
Effect of 13-MTD on caspase-3 activity (A) and relative viability (B) of SKBR-3 cells. Cells were incubated with the fatty acid 
samples (0.25 mM) for 2 or 4 h. Caspase activity in the cell lysate and the cell viability were determined as described in the 
method section. Data are mean ± SE of triplicate analyses. Data not sharing the same letter shows statistically significant differ-
ence at p < 0.05 by Tukey-Kramer test.
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DG to PC. Therefore, this enzyme could potentially pre-
vent DG species containing 13-MTD from moving into
phospholipid pool. Thus it become of interest to clarify
the biological machinery to channel 13-MTD into storage
lipid pool.
CLA known as anticancer fatty acid was also preferentially
incorporated into TG as well as the case for 13-MTD.
However, PL contained much higher concentration of
CLA compared with 13-MTD, suggesting that CLA rather
than MTD was more compatible with the membrane
structure. Conversely, PL containing 13-MTD may not be
acceptable to membrane structure, and for this reason the
large proportion of 13-MTD may be edited out to accumu-
late as TG. In this context, it is noteworthy that the mem-
brane fluidity is a factor to regulate the activities of
membrane-bound enzymes [30,31]. Thus it is plausible
that 13-MTD incorporated into PL affects the mitochon-
drial membrane fluidity because of its branching chain
structure, and hence modulates the enzyme activities lead-
ing to abnormal mitochondrial metabolism.
Positional distribution of 13-MTD also showed its charac-
teristics in the preference toward positon-2. In the case of
TG, sum proportion of 13-MTD at position 1 and 3 was
almost equal to that at position 2, showing that the indi-
vidual proportion at position 1 or 3 was lower than that
at position 2 (Fig. 4). Same trend in the positional distri-
bution was also seen with the case of structural lipid PC.
This characteristic also may be explained by the enzyme
specificity involved in the biosynthesis of these lipids.
This study reinforced the cytotoxicity of 13-MTD. 13-
MTD, as well as the known anticarcinogenic fatty acid
CLA, induced apoptotic cell death of breast cancer cells.
Several lines of studies demonstrated that CLA induced
apoptosis via caspase-dependent mechanism [29,32-34].
However, the mechanism action of 13-MTD differed from
that of CLA. Incubation of the cells with 13-MTD induced
no changes in the caspase activity and its gene expression
(Figs. 5 and 7). Furthermore, inclusion of caspase-3 inhib-
itor in the culture medium did not prevent the cells from
the cytotoxicity of 13-MTD (Fig. 6). These findings sug-
gested that 13-MTD induced apoptosis via caspase-inde-
pendent signal transduction.
The mitochondria are playing central role in both caspase-
dependent and caspase-independent death pathway
[26,35]. Mitochondria respond to multiple death stimuli
which induce mitochondrial membrane permeabiliza-
tion, and cause the release of apoptotic molecules such as
cytochrome C or apoptosis inducing factor (AIF). Incuba-
tion of the breast cancer cells for 4 h with 13-MTD caused
disruption of mitochondrial integrity (Fig. 10). This
observation suggested that 13-MTD permeabilized the
mitochondrial membrane, and proapoptotic molecules
were released from mitochondria to trigger the chromatin
condensation. These proapoptotic molecules can also be
released from mitochondria by cellular perturbations that
cause a sudden increase in intracellular calcium level [25].
However, 13-MTD induced no mobilization of calcium
hence no increase in the intracellular calcium concentra-
tion (Fig. 9). Thus 13-MTD appeared to induce apoptosis
without changing cellular calcium level.
Effect of caspase-3 inhibitor on cytotoxicity (A) and induction  of apoptosis (B) by13-MTD Figure 6
Effect of caspase-3 inhibitor on cytotoxicity (A) and induction 
of apoptosis (B) by13-MTD. Cells pre-cultured for 24 h were 
incubated with PBS (no inhibitor), caspase-3 inhibitor (20 µM 
Z-DEVD-FMK) and negative control inhibitor (20 µM Z-FA-
FMK) for 60 min and then further incubated with 0.25 mM of 
fatty acids samples for 4 h. On completion of the incubation, 
cell viability was determined by MTS assay (A), and induction 
of apoptosis was assayed as described in legend to Fig. 2 (B). 
Data are mean ± SE of triplicates analyses. Data not sharing 
the same letter within the treatment shows the statistically 
significant difference at p < 0.05 by Tukey-Kramer test.
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The most notorious apoptotic factors released from per-
meabilized mitochondria are cytochrome C and AIF.
However, the results shown in this study (Figs. 5-6) may
rule out the involvement of cytochrome C in the death
pathway of 13-MTD induced apoptosis. AIF was therefore
the most plausible candidate of death signal transducer
for 13-MTD induced apoptosis. Immunocytochemical
analysis supported this view. The percentage of AIF punc-
tuated apoptotic nuclei was increased by 13-MTD treat-
ment (Fig. 11), suggesting that nuclear AIF translocation
could be the main death signaling system. More recently,
it has been demonstrated that permeabilized mitochon-
dria can also release other proapoptotic factors such as
Smac/Diablo [36,37] or HtrA2/Omi [38-40]. Involve-
ment of these factors in the action mechanisms of 13-
MTD should be explored in the coming study.
AIF is usually present in the intermembrane space of mito-
chondria, and translocated from mitochondria to nucleus
to initiate apoptosis [41]. In most cases of apoptotic cell
death, the release of AIF appeared to coincide with the loss
of mitochondrial membrane integrity [42-44]. Permeabi-
lization of mitochondrial membrane triggers the death
pathway by releasing the proapoptotic molecules. The lib-
eration mode and rate of these molecules appeared to
depend on the death stimulus [44,45]. In the case of 13-
MTD treatment, translocation of AIF may precede the
release of cytochrome C, and play a crucial role in the
progress of cell death. AIF translocation after 13-MTD
treatment may be accompanied by the release of cyto-
chrome C. However, this event usually occurs during the
end stage of cell death, and has been considered to be lim-
ited significance for the completion of apoptosis [46].
13-MTD differed from CLA in that this unusual fatty acid
preferentially induced translocation of AIF rather than
release of cytochrome C. This feature may bear relevance
with its chemical structure which appeared to be less tol-
erable to the membrane structure than CLA. Phospholip-
ids isolated from 13-MTD treated cells contained 13-MTD
to some extent, suggesting that similar changes in the fatty
acid composition took place in the phospholipids of
mitochondrial membrane. Incorporation of phospholip-
ids containing 13-MTD into membrane structure may
impose a change in the membrane environment as is the
case of death stimulus. The physicochemical properties of
CLA are similar to those of unsaturated fatty acid, and may
be more acceptable as membrane component. Thus the
change in the membrane lipid profile elicited by incorpo-
ration of 13-MTD alternatively may affect the permeabil-
ity of mitochondrial membrane, and result in the
preceded release of AIF. The physicochemical properties
of 13-MTD thereby may be a critical determinant to
induce AIF translocation.
Majority of proapoptotic stimuli, including anticancer
drug require a caspase dependent death pathway. It has
been shown that AIF determines the chemoresistance of
non-small-cell lung cancer cells [47]. In this case, activa-
tion of caspase cascade was insufficient to kill cancer cells,
and an AIF-mediated death pathway played an important
role for the induction of apoptosis [47]. Although it may
be difficult to achieve mM concentration of 13-MTD in
humans, present findings warrant further investigation to
develop additional chemotherapeutic agent that is effec-
tive to kill the cancer cells resistant to the induction of
apoptosis by conventional anticancer drug.
Conclusion
In conclusion, we report that the 13-MTD was incorpo-
rated into glycerolipids of SKBR-3 cells with the prefer-
ence for triglycerides rather than phospholipids,
suggesting that incorporation of phospholipids contain-
ing 13-MTD into membrane structure influenced the
membrane environment as are the case of death stimulus.
Treatment with 13-MTD induced no change in the activity
and expression of caspase 3. Furthermore, 13-MTD
induced no mobilization of cellular calcium. However,
13-MTD altered the mitochondrial transmembrane
potential and induced AIF translocation from mitochon-
drial to nuclear after 4 hrs of treatment. These results sup-
ported the view that incorporation of 13-MTD into
cellular lipids triggered apoptosis via caspase-independ-
ent pathway.
Effect of 13-MTD on the expression of several regulatory  genes involved in the apoptosis induction in SKBR-3 cells Figure 7
Effect of 13-MTD on the expression of several regulatory 
genes involved in the apoptosis induction in SKBR-3 cells. 
Cells pre-cultured for 24 hours were treated with the fatty 
acids for 4 h, and gene expression were measure by real time 
PCR. The relative change in gene expression was quantified 
essentially based on the 2 -∆∆CT methods. Data are mean ± 
95% confidence intervals of triplicates analyses. Data not 
sharing the same letter shows the statistically significant dif-
ference at p < 0.05 by Tukey-Kramer test.
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Materials and methods
Chemicals
Enzyme phospholipase A2  was purchased from Sigma
Chemicals Co.(Tokyo, Japan) and pancreatic lipase from
Funakoshi(Tokyo, Japan). The primers were obtained
from Hokkaido System Science Co., Ltd (Hokkaido,
Japan). The RNA isolation kit was purchased from Wako
(Osaka, Japan) and cDNA synthesis kit from Invitro-
gen(Tokyo, Japan). Other chemicals were all guaranteed
grade, and obtained from domestic suppliers.
Cell and tissue culture
Human breast cancer cell line SKBR-3 was purchased from
Dainippon pharmaceuticals Co. (Osaka, Japan). Cells
were maintained and sub cultured according to the sup-
plier's recommendation. Culture medium for SKBR-3 was
McCOY's 5A containing 10% FBS. Cells were cultured in a
humidified atmosphere of 5% CO2 at 37°C
Cell cytotoxicity assay
Test substances of free fatty acids were neutralized and dis-
solved in PBS containing 0.8% tween 80. Cell cytotoxicity
titration curve was constructed with serial dilution of the
test substances in a 96-well microplate. Cells seeded at
density of 700 cells/well were incubated with serially
diluted test substances, and the viable cell numbers were
determined by MTS assay according to the manufacture's
instruction (CellTiter®  AQueous Non-Radioactive Cell
Proliferation Assay, Promega Co., Madison, USA). Cell
cytotoxicity was thus expressed as the relative viability
against control cells treated only with the vehicle solu-
tions.
Quantitation of apoptotic cells
SKBR-3 cells (1 × 104 cells/dish) were pre-incubated in the
medium for 2 hours, and cultured further with fatty acid
samples for 4 hours. At the end of the treatment, cells were
washed with PBS and resuspended in 100 µl of binding
buffer containing Anexin V (MBL, Nagoya, Japan) and
incubated for 30 min. Cells were washed with binding
buffer, and apoptotic cells stained with Anexin V were
counted with a fluorescence microscope. Data were
expressed as percentages of apoptotic cells in the total
cells.
Lipid extraction and fractionation
SKBR-3 cells were seeded in 90 × 17 mm petridish at den-
sity of 1 × 104 /dish and grown to 80% confluence. Cells
were subsequently incubated with 0.25 mM fatty acids
dissolved in PBS containing 0.8% Tween 80 for 3, 6 and
24 h, respectively. After incubation, surface of the cultures
were washed twice with PBS. Cells were scraped, centri-
fuged for 10 min at 700 × g and extracted with 1 ml of
chloroform/methanol (2:1, by vol.) at 40°C for 60 min.
The extract was split into chloroform and methanol water
layer by addition of 0.2 ml water. Lipids partitioned into
chloroform layer were concentrated and spotted onto
HPTLC plates (Merck, Darmstadt, Germany) for a separa-
tion of triacylglycerol, (TG) and phospholipid (PL) frac-
tions as described previously [3]. In the case of separation
of phospholipids, the HPTLC plates were developed step-
wise with chloroform/acetone/methanol (9:0.5:0.5, by
vol.), chloroform/ethyl acetate/methanol/2-propanol/tri-
ethylamine/water (6.4: 1.5: 1.7: 0.05: 0.3: 0.2, by vol.).
Phosphatidylethanolamine (PE) and phosphatidylcho-
line (PC) were identified by comparison of Rf (retardation
factor) value with authentic standards. TG and PL factions
were extracted and methanolysed with methanolic hydro-
chloric acid as described elsewhere [14]. The fatty acid
methyl esters produced were analyzed by a gas chromato-
graph (Model GC-2010; Shimadzu, Kyoto, Japan) with a
capillary column (DB-FFAP column 0.25 mm ID × 30 m;
J&W Scientific, CA, USA). Injector and detector tempera-
tures were 210°C. The oven temperature was pro-
grammed as follows: the initial temperature was 50°C for
1 min, raised to 100°C at 10°C/min, thereafter to final
temperature of 240°C at 5°C/min, and kept for 26 min.
The chromatograms were analyzed by GC Solution Soft-
ware (Shimadzu).
Positional distribution of fatty acid
The method of enzymatic hydrolysis was used to analyze
the positional distribution of fatty acid in PL and TG. PE
Cytotoxicity of 13-MTD to SKBR-3 cells in the presence or  absence of catalase Figure 8
Cytotoxicity of 13-MTD to SKBR-3 cells in the presence or 
absence of catalase. Cells were pre-cultured for 24 h. Cata-
lase (100 units/ml) was added at indicated time of incubation 
with 0.25 mM of fatty acid samples, and the relative cell via-
bility was measured after 24 h by MTS assay. Data are mean 
± SE of 8 analyses. Asterisk shows the statistically significant 
difference from PBS or C14:0 at p < 0.05 by Tukey-Kramer 
test.
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and PC fractions were hydrolyzed with phospholipase A2
from bee venom (Sigma Chemicals Co.) About 1 mg of PE
or PC in 1 ml diethyl ether was treated with 0.5 ml (850
U) phospholipase A2 dissolved in 1 M Tris buffer (pH 7.5)
containing 4 mM calcium chloride. The enzyme reaction
was monitored by examining the reaction products by
HPTLC. Fractions of PE or PC were completely hydrolyzed
to give rise to lyso PE or lyso PC, respectively. The released
free fatty acid and lyso PE or lyso PC were analyzed for
fatty acid compositions of sn-2 and sn-1, respectively.
In the case of TG, pancreatic lipase (Funakoshi, Japan)
was used for the enzymatic hydrolysis. About 50 µg of TG
was mixed stepwise with 0.5 ml of 1 M Tris buffer (pH
8.0), 50 µl of 2.2%calcium chloride and 0.125 ml of
0.05% cholic acid sodium salt. The mixture was incubated
at 37°C for 1 min. Pancreatic lipase (40 µl, 1 U/µl) was
added to this solution and shaken vigorously at 37°C for
1 h. The reaction was stopped by the addition of 0.5 ml of
ethanol and 6 M HCl, and extracted with 4 ml of diethyl
ether. The extract was washed with 1.5 ml of distilled
water and dried over sodium sulphate. The reaction prod-
ucts, free fatty acid (FFA) and monoacylglycerol (MG),
were separated by HPTLC with hexane/diethyl ether/ace-
tic acid (5:5:0.1, by vol.), and analyzed for fatty acid com-
position of n-1,3 and n-2, respectively.
Measurement of caspase activity
Cells were incubated with fatty acid sample for 2 or 4
hours and collected to measure caspase activity. Cells were
lysed in buffer containing 10 mM Tris-HCl (pH 7.5), 10
mM Na2H2PO4/Na2HPO4, 130 mM NaCl, 1% Triton X-
100 and 10 mM sodium pyrophosphate. The cell lysates
(45 µl) were mixed with 5 µl of fluorogenic caspases-3
substrate (500 µM) DEVD-R110 (Roche Diagnostics,
Mannheim, Germany) in 96-well micro titer plate accord-
ing to the manufacturer's instruction. The plate was incu-
bated at 37°C for 1 h, and then fluorescence was
monitored with excitation and emission wavelengths at
485 and 535 nm, respectively.
Real time PCR
Total RNA was extracted from 80% confluent SKBR-3 cells
by RNA isolation kit, (Isogen, Wako, Osaka, Japan). A first
strand cDNA synthesis was conducted by cDNA synthesis
kit (Invitrogen, Japan). The sequences of the forward and
reverse primers used were; caspases 3 (5'-GCCTGAGCA-
GAGACATGACTCA-3 and 5'-TCATCCACACATACCAGT-
GCGA-3), caspases 8 (5'-
GATATATCCCGGATGAGGCTGAC-3 and 5'-TGACT-
GGATGTACCAGGTTCCC-3), P53 (5'-GGGATGTTT-
GGGAGATGTAAGAAATG-3 and 5'-
GTGGGCCCCTACCTACCTAGAATG-3), AIF (5'-
AGTAGTTTGCCCACAGTTGGTGTT-3 and 5'-
TCACTCTCTGATCGGATACCAGTTC-3), Bad (5'-CAGT-
GACCTTCGCTCCACATC-3 and 5'-AAGGAGACAG-
CACGGATCCTC-3), Bax (5'-
TCTGACGGCAACTTCAACTGG-3 and 5'-AGCCCATGAT-
GGTTCTGATCA-3), Bcl-XL (5'-CCTCAGCTGCCTCACT-
TCCTA 3 and 5'-CCATAGCTGTTCCTGATAGCTCC-3),
and GAPD (5'-TCTGGTAAAGTGGATATTGTTGCC-3 and
5'-CCTTCTTGATGTCATATTTGGC-3).
Each 20 µl PCR reaction contained 0.5 U DNA polymer-
ase (TaKaRa, Kyoto, Japan), 20 mM Tris-HCl (pH 8.4),
100 mM KCl, 0.1 mM EDTA, 1 mM DTT, 0.5% Tween 20,
0.5% Nonident P-40, 50% glycerol), 2.5 mM dNTP, 3 µg
cDNA, 10 pmol primers and 0.2 µl of 1 × working solu-
tion of SYBR Green II (Takara, Shiga, Japan). The real time
quantitative PCR was conducted in the thermocycler (iCy-
cler, BioRad, Hercules, CA). The temperature program for
real time analysis consisted of 30 cycles of 90 °C for 30 s,
58 °C for 30 s and final extension step at 72 °C for 30 s.
Threshold cycle (CT) numbers were calculated during PCR
amplification by using the iCycler data analysis software.
The house-keeping GAPD genes were internal control to
normalize the PCR for the amount of template cDNA. Rel-
ative change in gene expression was quantified essentially
based on the 2-∆∆CT methods as described previously [15].
The 2-∆∆CT  denotes the relative change of target gene
expressed in sample-treated cells compared with that in
reference cells [15]. Because the normalized concentration
Effect of 13-MTD on cellular calcium mobilization in SKBR-3  cells Figure 9
Effect of 13-MTD on cellular calcium mobilization in SKBR-3 
cells. SKBR-3 cells were seeded into black 96-well plate at 
105 cells/well, and incubated for 1 day. Cells were loaded 
with 4 µM Fluo 3-AM for 30 min, and subsequently stimu-
lated with 0.125, 0.25 and 0.5 mM fatty acids in 0.8% Tween 
80 in PBS. The increases in fluorescence were measured 25 
times with 0.15 s intervals. Data are mean ± SE of 38 repli-
cate analyses. Data not sharing the same letter are signifi-
cantly different at p < 0.05 by Tukey-Kramer test.
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of cDNA template was used in this experiment, 2-∆CT rep-
resents the relative change of gene expression between
treated and untreated cells. The equation that describes
the relative change in threshold cycle is therefore
∆CT = CT (sample)-CT (reference)
where CT is the threshold cycle reflecting the cycle number
at which the fluorescence generated within a reaction
process crosses the threshold level. In this study, sample
cDNAs were serially diluted, and the mean CT and its 95%
confidence interval were estimated by linear regression.
Measurement of cellular calcium mobilization
SKBR-3 cells were seeded into black 96-well plate at 105
cells/well, and incubated for 1 day. The cells were washed
twice with Hank's balanced salt solution (HBSS), and
loaded with 4 µM Fluo 3-AM for 30 min in HBSS. The
plates were washed with HBSS, transferred to microplate
reader (Wallac 1420 Multilabel Counter, Parkin Elmer
Effect of 13-MTD on mitochondrial membrane integrity of SKBR-3 cells Figure 10
Effect of 13-MTD on mitochondrial membrane integrity of SKBR-3 cells. Cells cultured for 24 h on coverlips were incubated 
with 0.25 mM fatty acid sample for 4 h, and loaded with MitoCapture (Biovision, USA) reagent for 20 min at 37°C under 5% 
CO2 atmosphere. Cells were observed with a fluorescence microscope using band-pass filter. MitoCapture aggregates and flu-
oresces red in the mitochondria of healthy cells. However, in apoptotic cells, MitoCapture cannot accumulate in the mitochon-
dria, it remains as monomers in the cytoplasm, and fluoresces green. Counting of mitochondria disrupted cells in total number 
of 40 cells were made for 4 to 6 separate microscopic fields, and the percentages are shown (B). Data not sharing the same let-
ter are significantly different at p < 0.05 by Tukey-Kramer test.
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Co., Turka, Finland), and the basal fluorescence levels
were recorded. Cells were loaded with 0.25 mM fatty acids
samples, mixed for 30 s, and the increases in fluorescence
were measured 25 times with 0.15 s intervals. Excitation
and emission wavelength were 485 and 535 nm, respec-
tively.
Effect of 13-MTD on nuclear translocation of AIF in SKBR-3 cells Figure 11
Effect of 13-MTD on nuclear translocation of AIF in SKBR-3 cells. Cells were grown for 24 h on coverslips and treated with 
0.25 mM fatty acid samples for 6 h. After the treatment, cells were stained with Hoechst 33258 and AIF as described in the 
method section (A). Counting of AIF punctuated nuclei in total number of 40 cells were made for 4 to 6 separate microscopic 
fields, and the percentages of AIF translocated cells are shown (B). Data not sharing the same letter are significantly different at 
p < 0.05 by Tukey-Kramer test. Arrow shows the AIF translocated nucleus.
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Immunocytochemistry
For immunocytochemical analysis, cells grown on cover-
slips were fixed with 4% paraformaldehyde in PBS for 20
min, and washed twice with PBS. The cells were further
permeabilized with 0.1% Triton X-100 in PBS for 20 min.
After two washes with PBS, cells were incubated with
diluted (1/200) rabbit anti-AIF (Chemicon International
Co., CA, USA) in PBS containing 0.1% Tween 20(PBST)
for 2 hours at room temperature. The cells were washed
three times with PBST, and incubated with FITC-labeled
goat anti-rabbit IgG (Biosource International Co., CA,
USA) in PBST for 2 hours. After three washes with PBST,
the cells were loaded with 1 µg/ml of Hoechst 33258 to
stain DNA. Coverslips were then placed on a slide glass
with cell-side down, and were covered with nail lacquer to
prevent them from drying. The fluorescent images were
visualized by conventional (Model BX41, Olympus Co.,
Tokyo, Japan) or confocal fluorescence microscopy (Radi-
ance 2100, Bio-Rad Laboratories, Inc. Tokyo, Japan).
Statistical analyses
Data are represented as mean ± SE except otherwise stated.
The statistical significance was evaluated by Tukey-Kramer
tests [16] or Student's t-test. The criterion for statistical sig-
nificance was p <0.05.
List of abbreviations
13-MTD, 13-methyltetradecanoic acid; BCFA, branched-
chain fatty acid; C14:0, myristic acid; C18:0, stearic acid;
HPTLC, high-performance thin layer chromatography; PL,
phospholipid; TG, triglycerides; MG, monoacylglycerol;
DG, diglyceride; PE, phosphatidylethanolamine; PC,
phosphatidylcholine; FFA, free fatty acid; PBS, phosphate-
buffered saline; FBS, fetal bovine serum, FA, fatty acid;
PCR, polymerase chain reaction; IgG, immunoglobulin G;
HBSS, Hanks' balanced salt solution; cDNA, complemen-
tary DNA; Rf, retention factor; DMSO, dimethyl sulfoxide;
DTT, dithiothreitol; RNA, ribonucleic acid; SE, standard
error; SEM, standard error of the mean; TAG, triacylglyc-
erol.
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